What's New in Photon Counting CT? — July 11, 2026
AI-summarised digest of 4 PubMed articles on Photon Counting CT published in the last 7 days.
Jump to category
What’s New in Photon Counting CT?
July 11, 2026 · 4 articles · 8 research themes · covering July 04, 2026 – July 11, 2026
Overview
Across these recent studies and reviews, a clear theme is the push to translate photon-counting detector CT’s (PCD-CT) physical advantages—especially higher spatial resolution and spectral information—into practical diagnostic gains. Work in coronary CT angiography shows that deep-learning (CNN) denoising can improve submillimeter non-calcified coronary plaque assessment under varying acquisition and reconstruction conditions, aiming to strengthen confidence in detecting coronary atherosclerosis beyond calcified disease.
In parallel, the spectral capabilities of PCD-CT are being actively engineered for more complex contrast scenarios. A dual-contrast, K-edge-based material decomposition approach demonstrates simultaneous quantification of iodine, gadolinium, and calcium for CT-based dual-contrast arthrography, potentially improving interpretation when multiple contrast agents are co-administered.
Finally, the field is also benchmarking PCD-CT against emerging AI-accelerated MRI strategies for lung nodule detection. A prospective comparison in healthy adults evaluates an AI-powered compressed sensing lung MRI protocol against PCD-CT within a clinically relevant time window, highlighting how lower-burden imaging alternatives may complement or reduce reliance on CT for screening. Meanwhile, a review on temporal bone imaging positions this indication as an ideal test bed for determining whether PCD-CT’s resolution and dose/noise efficiency translate into measurable clinical benefits for fine anatomical structures.
PCD-CT for Coronary Atherosclerosis & Plaque Characterization
Deep-learning denoising for ultrahigh-resolution photon-counting detector CT: phantom and in vivo evaluation of non-calcified coronary plaques.
The study evaluated convolutional neural network (CNN) denoising for ultrahigh-resolution photon-counting detector (PCD) coronary CT angiography (CCTA) to assess non-calcified coronary plaques (NCPs) in a dynamic lipid-rich/fibrotic coronary phantom and in consecutive in-vivo patients with NCPs. CNN denoising applied to PCD-CT reconstructions (sharp vascular kernel Bv64, 0.2/0.4 mm slices, quantum iterative reconstruction QIR levels 3/4, with vs without denoising) improved image quality for non-calcified plaque evaluation under varying acquisition/reconstruction conditions. This supports using deep-learning denoising to enhance submillimeter plaque characterization on ultrahigh-resolution PCD-CT, potentially improving diagnostic confidence for coronary atherosclerosis beyond calcified disease.
Hyska S, Hagar MT, Osoria-Velasquez J et al. · The international journal of cardiovascular imaging · (2026) · View on PubMed ↗
AI-Accelerated MRI for Lung Nodule Detection
Diagnostic performance of a single breath-hold lung MRI scan with AI-powered compressed sensing for nodule detection in comparison to photon counting detector-CT.
This single-center prospective study compared a single breath-hold, AI-powered compressed sensing accelerated 3-T lung MRI protocol (3D T1w-FFE, acceleration factor 9) against photon-counting detector CT (PCD-CT) as the reference standard for lung nodule detection in 148 healthy adults. The key finding was the diagnostic performance of the accelerated MRI approach (using Lung-RADS scoring and nodule size assessment) relative to PCD-CT for identifying nodules within a 24-hour window. Clinically, it suggests whether AI-CS MRI can serve as an effective, lower-burden alternative or complement to PCD-CT for lung nodule screening.
Palmisano A, Piccinni G, Serra D et al. · European radiology · (2026) · View on PubMed ↗
PCD-CT Clinical Applications: Temporal Bone Imaging
Photon-counting detector computed tomography for temporal bone: does higher resolution matter?
This review article assessed photon-counting detector computed tomography (PCD-CT) for temporal bone imaging, focusing on whether the technology’s higher spatial resolution translates into meaningful clinical benefits compared with conventional energy-integrating detector CT (EID-CT). The key conclusion was that temporal bone submillimeter structures make this an ideal test bed, and the emerging literature is being evaluated to determine if improved resolution/noise/dose efficiency improves diagnostic outcomes. Scientifically and clinically, it frames how PCD-CT should be adopted for temporal bone indications where fine anatomy is critical.
Epperson MV, Leng S, Lane JI et al. · Current opinion in otolaryngology & head and neck surgery · (2026) · View on PubMed ↗
Dual-Energy/K-edge Spectral Quantification for Contrast Agents
A pilot study: dual-contrast arthrography using photon-counting detector computed tomography with gadolinium and iodine contrasts.
This pilot study developed and tested a dual-contrast PCD-CT material decomposition method to simultaneously separate and quantify iodine, gadolinium, and calcium for dual-contrast arthrography using K-edge-based spectral imaging. Using calibration phantoms (including iodine, gadolinium, calcium, and iodine–gadolinium mixtures) and an ex vivo pig-tail specimen on a benchtop PCD-CT system, the approach enabled concurrent quantification of the three materials rather than relying on conventional CT/MR separation. This is significant because it could improve CT-based arthrography when iodine and gadolinium are co-administered for complementary assessment, enabling more accurate spectral interpretation.
Deng X, Day J, Masella O et al. · Physics in medicine and biology · (2026) · View on PubMed ↗ · Free PDF ↗
Generated automatically on July 11, 2026. Covers PubMed articles published July 04, 2026 – July 11, 2026. Summaries are AI-generated; always consult the original publication for clinical or research decisions.